Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) FCF Margin (2016 - 2025)

Historic FCF Margin for Fortress Biotech (FBIO) over the last 12 years, with Q3 2025 value amounting to 34.65%.

  • Fortress Biotech's FCF Margin rose 929300.0% to 34.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 106.16%, marking a year-over-year increase of 574300.0%. This contributed to the annual value of 139.04% for FY2024, which is 127600.0% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's FCF Margin is 34.65%, which was up 929300.0% from 167.92% recorded in Q2 2025.
  • Fortress Biotech's FCF Margin's 5-year high stood at 34.65% during Q3 2025, with a 5-year trough of 347.88% in Q1 2023.
  • Its 5-year average for FCF Margin is 178.42%, with a median of 191.57% in 2023.
  • Per our database at Business Quant, Fortress Biotech's FCF Margin crashed by -1626600bps in 2022 and then skyrocketed by 2194600bps in 2023.
  • Quarter analysis of 5 years shows Fortress Biotech's FCF Margin stood at 222.44% in 2021, then tumbled by -31bps to 292.22% in 2022, then soared by 40bps to 175.29% in 2023, then skyrocketed by 51bps to 85.36% in 2024, then soared by 59bps to 34.65% in 2025.
  • Its FCF Margin was 34.65% in Q3 2025, compared to 167.92% in Q2 2025 and 148.89% in Q1 2025.